TRCT
NUVL

Tower Research Capital (TRC)’s Nuvalent NUVL Stock Holding History

Tower Research Capital (TRC)’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$407K Buy
3,976
+2,837
+249% +$289K 0.01% 1065
2025
Q4 		$115K Sell
1,139
-825
-42% -$81.3K ﹤0.01% 1853
2025
Q3 		$170K Sell
1,964
-1,178
-37% -$93.1K ﹤0.01% 1597
2025
Q2 		$240K Buy
3,142
+588
+23% +$43K 0.01% 1610
2025
Q1 		$181K Sell
2,554
-1,430
-36% -$112K 0.01% 1422
2024
Q4 		$312K Buy
3,984
+3,661
+1,133% +$342K 0.01% 1379
2024
Q3 		$33K Sell
323
-10,052
-97% -$834K ﹤0.01% 2953
2024
Q2 		$787K Buy
10,375
+8,735
+533% +$621K 0.01% 950
2024
Q1 		$123K Sell
1,640
-1,479
-47% -$118K ﹤0.01% 1716
2023
Q4 		$230K Buy
3,119
+2,476
+385% +$153K ﹤0.01% 1983
2023
Q3 		$29.6K Buy
643
+187
+41% +$8.3K ﹤0.01% 3039
2023
Q2 		$19.2K Sell
456
-8,651
-95% -$327K ﹤0.01% 3420
2023
Q1 		$238K Buy
9,107
+8,265
+982% +$244K 0.01% 1267
2022
Q4 		$25K Sell
842
-6,329
-88% -$177K ﹤0.01% 2921
2022
Q3 		$140K Sell
7,171
-6,597
-48% -$110K ﹤0.01% 2250
2022
Q2 		$187K Buy
13,768
+13,032
+1,771% +$138K ﹤0.01% 1811
2022
Q1 		$10K Sell
736
-1,192
-62% -$17.3K ﹤0.01% 4326
2021
Q4 		$37K Buy
1,928
+1,199
+164% +$26.7K ﹤0.01% 3030
2021
Q3 		$16K Buy
+729
New +$21.1K ﹤0.01% 3933

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tower Research Capital (TRC)'s NUVL Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Nuvalent (NUVL) stake by 249% in Q1 2026, buying an estimated $289K and bringing the position to 3,976 shares worth $407K. The position accounts for 0.01% of the portfolio, ranked #1065.

Tower Research Capital (TRC) first reported a position in NUVL in Q3 2021 and has held it in 19 quarters since. The position peaked at $787K in Q2 2024. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Tower Research Capital (TRC) held 3,976 shares of Nuvalent worth $407K as of Q1 2026.
  • Tower Research Capital (TRC) bought 2,837 Nuvalent shares in Q1 2026, an estimated $289K.
  • Nuvalent made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1065 holding.
  • Tower Research Capital (TRC) first reported a position in Nuvalent in Q3 2021 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s Nuvalent position peaked at $787K in Q2 2024.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.